Ensysce Biosciences, Inc. (ENSC)の価格はいくらですか

Ensysce Biosciences, Inc. (ENSC)の価格は$0.5275です

Ensysce Biosciences, Inc. (ENSC)の時価総額は何ですか

Ensysce Biosciences, Inc. (ENSC)の時価総額は$1.25Mです

Ensysce Biosciences, Inc.（ENSC）株式分割

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.

年	株式分割	分割比率	累積分割比率
2024-12-06	1:15	x0.066666666666667	x0.00027777777777778
2023-03-31	1:12	x0.083333333333333	x0.0041666666666667
2022-10-28	1:20	x0.05	x0.05

年

株式分割

分割比率

累積分割比率

2024-12-06

1:15

x0.066666666666667

x0.00027777777777778

2023-03-31

1:12

x0.083333333333333

x0.0041666666666667

2022-10-28

1:20

x0.05

企業	株式分割の回数	累積分割比率	国
Novo Nordisk A/S NVO.US	5	x199	DK
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Regeneron Pharmaceuticals, Inc. REGN.US	0	-	US
UCB SA UCB.BR	0	-	BE
CSL Limited CSL.AX	1	x3	AU

企業

株式分割の回数

累積分割比率

国